SCHEMBL3434544

SCHEMBL3434544

O=C(N1CCc2c(cccc2-c2ccccc2Cl)C1)C(F)(F)F

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABHD6 Q9BV23 5/20 0.53
ESR1 P03372 4/20 0.49
ESR2 Q92731 4/20 0.49
PDE4B Q07343 1/20 0.45
TDP1 Q9NUW8 1/20 0.44
LMNA P02545 2/20 0.44
ALDH1A1 P00352 1/20 0.44
HPGD P15428 1/20 0.44
HTT P42858 1/20 0.44
GAA P10253 1/20 0.43
TAS1R3 Q7RTX0 1/20 0.40
TAS1R1 Q7RTX1 1/20 0.40
TAS1R2 Q8TE23 1/20 0.40
RAB9A P51151 1/20 0.40
CPT2 P23786 1/20 0.40
CPT1A P50416 1/20 0.40
CYP3A4 P08684 1/20 0.39
CYP2D6 P10635 1/20 0.39
CYP2C9 P11712 1/20 0.39
CYP2C19 P33261 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL176110 0.85 ESR1 (0.47) ABHD6ESR1ESR2PDE4BLMNA
SCHEMBL15686737 0.84 TDP1 (0.47) ABHD6PDE4BTDP1LMNAALDH1A1
SCHEMBL169052 0.81 ESR1 (0.44) ABHD6ESR1ESR2PDE4BLMNA
SCHEMBL17130540 0.80 ESR1 (0.55) ABHD6ESR1ESR2TDP1LMNA
SCHEMBL3435000 0.79 ESR1 (0.44) ABHD6ESR1ESR2LMNAGAA
SCHEMBL23553488 0.79 ESR1 (0.52) ABHD6ESR1ESR2PDE4BRAB9A
SCHEMBL8177222 0.79 ESR1 (0.56) ABHD6ESR1ESR2
SCHEMBL30814383 0.79 ESR1 (0.52) ABHD6ESR1ESR2PDE4BRAB9A
SCHEMBL169273 0.78 PDK2 (0.41) ABHD6ESR1ESR2LMNAGAA
SCHEMBL7402991 0.78 ESR1 (0.51) ABHD6ESR1ESR2ALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2424532-B1 COMPOUNDS FOR INDUCING CELLULAR APOPTOSIS QUEEN MARY & WESTFIELD COLLEGE (GB) 2014-09-24 EP disclosed
US-8716302-B2 Compounds for inducing cellular apoptosis QUEEN MARY & WESTFIELD COLLEGE (GB) 2014-05-06 US disclosed
US-8716302-B2 Compounds for inducing cellular apoptosis QUEEN MARY & WESTFIELD COLLEGE (GB) 2014-05-06 US disclosed
US-20120101115-A1 Compounds For Inducing Cellular Apoptosis QUEEN MARY AND WESTFIELD COLLEGE (GB) 2012-04-26 US disclosed
US-20120101115-A1 Compounds For Inducing Cellular Apoptosis QUEEN MARY AND WESTFIELD COLLEGE (GB) 2012-04-26 US disclosed
WO-2010125343-A1 COMPOUNDS FOR INDUCING CELLULAR APOPTOSIS QUEEN MARY AND WESTFIELD COLLEGE (GB) 2010-11-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120101115-A1 Compounds For Inducing Cellular Apoptosis BAD, BAX, CASP3 ABHD6 1808/4885ESR1 3474/4885ESR2 2946/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.